Keywords
How to Cite
Abstract
The objective of this study is to expose the main concepts about borderline ovarian tumors and their pathological aspects. And, as secondary objectives, to evaluate the diagnostic measures, prognoses and treatment of these tumors, in addition to tracing the epidemiological profile of the affected patients. A review of articles was carried out in the Medical Literature Analysis and Retrievel System Online (MEDLINE), Scientific Electronic Library Online (SciELO), Latin American and Caribbean Literature in Health Sciences (LILACS) and PubMed databases, with the following Descriptors in Health Sciences (DeCS): Tumor; Borderline ovarian tumor; Revision. Selecting articles between the periods of 1996 to 2023, in English, Portuguese and Spanish. In summary, early histological diagnosis and assessment of disease staging are essential for a favorable prognosis against the disease, in addition to adequate surgical therapy. Observational and surgical studies are necessary for the improvement of techniques and the evolution of medical management against borderline tumors.
References
- Sun Y, Wang Y, Mao L, Wen J, Bai W. Prevalence of abnormal uterine bleeding according to new International Federation of Gynecology and Obstetrics classification in Chinese women of reproductive age. Medicine [Internet]. 2018 Aug [cited 2019 Nov 20];97(31):e11457. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081150/
- Laughlin-Tommaso SK, Hesley GK, Hopkins MR, Brandt KR, Zhu Y, Stewart EA. Clinical limitations of the International Federation of Gynecology and Obstetrics (FIGO) classification of uterine fibroids. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Internet]. 2017 Nov 1 [cited 2020 Sep 1];139(2):143–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629115/
- Pereira A, Pérez-Medina T, Magrina JF, Magtibay PM, Rodríguez-Tapia A, Peregrin I, et al. International Federation of Gynecology and Obstetrics Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum: Estimation of Survival in Patients With Node-Positive Epithelial Ovarian Cancer. International Journal of Gynecologic Cancer. 2015 Jan;25(1):49–54.
- Wetterwald L, Sarivalasis A, Liapi A, Mathevet P, Achtari C. Lymph Node Involvement in Recurrent Serous Borderline Ovarian Tumors: Current Evidence, Controversies, and a Review of the Literature. Cancers [Internet]. 2023 Jan 1 [cited 2023 Jul 27];15(3):890. Available from: https://www.mdpi.com/2072-6694/15/3/890
- Zhang S, Yu S, Hou W, Li X, Ning C, Wu Y, et al. Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors. 2019 Sep 16;12(1).
- Corrallo, Andrea Castro Tumor borderline de ovário billateral: relato de caso em paciente de 29 anos de idade/ Andrea Castro Corrallo - São Paulo 2012
- WebPathology [Internet]. webpathology.com. Available from: http://www.webpathology.com/
- Berek JS, Renz M, Kehoe S, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. International Journal of Gynecology & Obstetrics. 2021 Oct;155(S1):61–85.
- Table: Estadiamento cirúrgico da FIGO para câncer de ovário, trompa de Falópio e peritôneo - Manuais MSD edição para profissionais [Internet]. Manuais MSD edição para profissionais. 2023 [cited 2023 Jul 27]. Available from: https://www.msdmanuals.com/pt-br/profissional/multimedia/table/estadiamento-cir%C3%BArgico-da-figo-para-c%C3%A2ncer-de-ov%C3%A1rio-trompa-de-fal%C3%B3pio-e-perit%C3%B4neo#
- Almeida SMV de, Alcantara FF de, Brito CGX de, Souza GCA de, Lafayette EA, Silva VBR da, et al. Compostos coordenados híbridos de platina no tratamento do câncer. Revista de Ciências Farmacêuticas Básica e Aplicada [Internet]. 2014 Jul 1 [cited 2023 Jul 27];35(3). Available from: https://rcfba.fcfar.unesp.br/index.php/ojs/article/view/106#:~:text=Atualmente%2C%20os%20f%C3%A1rmacos%20com%20platina
- Kreso A, Dick John E. Evolution of the Cancer Stem Cell Model. Cell Stem Cell [Internet]. 2014 Mar [cited 2019 Apr 10];14(3):275–91. Available from: https://www.sciencedirect.com/science/article/pii/S1934590914000575
- Jones, M. “Tumors: Current Concepts for Prognostic Factors and Clinical Management”. Clinical Obstetrics and Gynecology, sep 2006, vol.49, no.3, p.517-525 / 2006, Lippincott Williams & Wilkins
- Link, C., Reed, E., Sarosy, G., Kohn, E. “Borderline ovarian tumors”. Am. J. Med., 1996, vol.101, p.217-225.
- Nagai,Y., et al. “Diagnostic accuracy of intraoperative imprint cytology in ovarian epithelial tumors”. Int. J. Ginec. Obstet., 2001, vol.72, p.159-164.
- Oncologia ginecológica: aspectos atuais do diagnóstico e tratamento/ [organizadores] Marcos Desidério Ricci, José Roberto Morales Piato, Sebastião Piato, José Aristodemo Pinotti.- Barueri,SP: Manole, 2008, cap.16, p.197-210.
- Stemke-Hale K, Shipman K, Kitsou-Mylona I, de Castro DG, Hird V, Brown R, et al. Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes. Modern Pathology [Internet]. 2013 Apr 1 [cited 2023 Jul 27];26(4):544–52. Available from: https://www.nature.com/articles/modpathol2012194
- Micci F, Haugom L, Terje Cruickshank Ahlquist, Hege Kilen Andersen, Abeler VM, Davidson B, et al. Genomic aberrations in borderline ovarian tumors. 2010 Feb 26;8(1).
- Catasus L, Gallardo A, Cuatrecasas M, Prat J. PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters. 2008 Feb 1;21(2):131–9.
- Matulonis UA, Hirsch M, Palescandolo E, Kim E, Liu J, van Hummelen P, et al. High Throughput Interrogation of Somatic Mutations in High Grade Serous Cancer of the Ovary. Zhang L, editor. PLoS ONE. 2011 Sep 8;6(9):e24433.
- Ahmed HU, Arya M, Freeman A, Emberton M. Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? The Lancet Oncology. 2012 Nov;13(11):e509–17.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Dulio Alejandro La Rosa Jimenez, Luiz Felipe Neves Frazão, Eduarda Gabrielly Krynski de Oliveira, Juliano Infantino Maciel, Thainá Cardoso do Nascimento, Fernanda Cândida de Araújo Molinero, Hiury Portilho Fraga, Gabriela Mariá Gomes de Souza, Renata Moreira Gonçalves, Victor Botelho Bittencourt, Maximiana Aparecida dos Reis Fonseca, Cibele Avila Gomes, Leonardo Portilho Santos